<DOC>
	<DOCNO>NCT01002105</DOCNO>
	<brief_summary>This study Baclofen add-on standard treatment alcohol-dependent patient .</brief_summary>
	<brief_title>Baclofen Add-On Standard Treatment Alcohol- Dependent Patients</brief_title>
	<detailed_description>Double-blind , placebo-controlled , randomized trial compare 50 mg/day baclofen placebo 12 week , addition low-intensity psychosocial intervention program , 26-week 52-week follow-up observation . The percentage heavy drinking day abstinent day primary outcome measure , crave ; distress depression level ; self-efficacy ; social support family , friends significant others ; health-related quality life ( HRQL ) secondary outcome . Tolerability also examine .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>1 . ICD10 diagnosis alcohol dependence ( World Health Organization , 1993 ) ; 2 . Seeking treatment aim stop alcohol consumption ; 3 . Age range 18 60 year ; 4 . Last alcohol intake report 24 h precede observation ; 5 . Presence refer family member ; 6 . Written inform consent provision . . 1 . Serious hepatic , kidney , lung , neurological cardiovascular , disease ) ; 2 . Suicide risk , acute psychosis , severe depression , organic brain syndrome ; 3 . Dependence psychoactive substance nicotine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Baclofen</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Baclofen add-on standard treatment alcohol</keyword>
</DOC>